· · · · · 

Another Case Raises Hopes About Early Treatment for HIV-Positive Babies

Physicians in California believe that they have cleared HIV from a 9-month-old born with the virus.

Doctors in California believe that they have cleared HIV from the blood of a nine-month-old who seems to have been born with the virus. Though they can’t call it a “cure” or even say she is in remission because she continues to take medication, her doctors believe she has “sero-reverted to HIV-negative.”

· · · · · 

What’s Up With Women and HIV-Prevention Method PrEP?

The anti-retroviral drug Truvada, which is a combination of tenofovir and emtricitabine.

PrEP works when used properly. So why don’t women use it?

· · · · · 

First Trial Proposed of a Candidate Microbicide for Women Living with HIV

Red algae Griffithsia, from which HIV entry inhibitor griffithsin was isolated. (Fed. Laboratory Consortium Newslink)

On January 7, the Microbicide Trials Network (MTN) made the welcome announcement that it had added the first clinical trial of a microbicide for women living with HIV to its research portfolio. 

· · · · · 

From Tuskegee to Transparency: An Evolution in the Ethics and Accountability of Clinical Trials Involving Human Subjects

People who participate in clinical trials take the enormous step of volunteering to test a product that may be useful and, sometimes, life-saving if it turns out to be effective. They play an irreplaceable role in research to prevent, treat, and sometimes cure illness – as well as to find other ways to improve people’s health and lives.

· · · · ·